The Surprising Gain of The Open Network’s TON Amidst Telegram’s Legal Drama In the ever-volatile world of cryptocurrencies, one coin has managed to stand out as the week’s biggest gainer among high-cap coins. The Open Network’s TON (The Gram) has seen a significant surge in value, following the temporary exit of Telegram’s founder, Pavel Durov,…
Important Notice to The Trade Desk, Inc. (TTD) Shareholders NEW YORK, March 17, 2025 – The Gross Law Firm, a leading securities law firm, issues the following notice to all current shareholders of The Trade Desk, Inc. (TTD): Our firm has recently become aware of potential securities fraud concerning The Trade Desk, Inc. We are…
Important Notice for Rocket Lab USA, Inc. (RKLB) Shareholders: Securities Fraud Allegations NEW YORK, March 17, 2025 The Gross Law Firm, a leading national shareholder rights law firm, announces that it has commenced an investigation on behalf of shareholders of Rocket Lab USA, Inc. (NASDAQ: RKLB) concerning potential securities laws violations. The investigation focuses on…
Important Notice for Intellia Therapeutics, Inc. (NTLA) Shareholders: A Legal Perspective New York, NY – March 17, 2025 Greetings, dear readers! I hope this message finds you well and that your day has been filled with joy and intrigue. Today, I’d like to discuss an important matter that may have piqued the interest of some…
Important Notice for XPLR Infrastructure, LP (XIFR) Shareholders: A Legal Perspective New York, NY – March 17, 2025 The Gross Law Firm, a renowned securities litigation law firm, has issued a notice to shareholders of XPLR Infrastructure, LP (XIFR) regarding potential securities fraud claims. The notice comes in the wake of allegations that XPLR may…
Important Notice to Constellation Brands, Inc. (STZ) Shareholders: A Legal Perspective NEW YORK, March 17, 2025 – The Gross Law Firm, a leading securities fraud law firm, issues this notice to all investors who purchased or otherwise held Constellation Brands, Inc. (NYSE: STZ) securities between January 1, 2023, and December 31, 2024. The Firm is…
A Delightfully Charming and Eccentric Take on the FDA’s Lifting of the Clinical Hold on vTv Therapeutics’ VTVT Cadisegliatin Program Oh, what a splendidly surprising Monday it was in the world of pharmaceuticals! The United States Food and Drug Administration (FDA), known for its stern and unyielding demeanor, has shown a rare sign of warmth…
Urban One, Inc. to Host Conference Call for Fourth Quarter 2024 Financial Results On March 17, 2025, Urban One, Inc. (NASDAQ: UONEK, UONE) is set to hold a conference call for investors, financial analysts, and other interested parties to discuss the company’s financial results for the fourth quarter of 2024. The call is scheduled to…
